{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:49:35Z","timestamp":1775558975574,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["ERC-2014-StG 639776"],"award-info":[{"award-number":["ERC-2014-StG 639776"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1089413"],"award-info":[{"award-number":["OPP1089413"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1173572"],"award-info":[{"award-number":["OPP1173572"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Malaria control in sub-Saharan Africa relies upon prompt case management with artemisinin-based combination therapy (ACT). Ring-stage parasite mRNA, measured by\n                      <jats:italic>sbp1<\/jats:italic>\n                      quantitative reverse-transcriptase PCR (qRT-PCR), was previously reported to persist after ACT treatment and hypothesized to reflect temporary arrest of the growth of ring-stage parasites (dormancy) following exposure to artemisinins. Here, the persistence of ring-stage parasitaemia following ACT and non-ACT treatment was examined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Samples were used from naturally infected Malian gametocyte carriers who received dihydroartemisinin\u2013piperaquine (DP) or sulfadoxine\u2013pyrimethamine (SP\u2013AQ) with or without gametocytocidal drugs. Gametocytes and ring-stage parasites were quantified by qRT-PCR during 42\u00a0days of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At baseline, 89% (64\/73) of participants had measurable ring-stage parasite mRNA. Following treatment, the proportion of ring-stage parasite-positive individuals and estimated densities declined for all four treatment groups. Ring-stage parasite prevalence and density was generally lower in arms that received DP compared to SP\u2013AQ. This finding was most apparent days 1, 2, and 42 of follow-up (p\u2009&lt;\u20090.01). Gametocytocidal drugs did not influence ring-stage parasite persistence. Ring-stage parasite density estimates on days 14 and 28 after initiation of treatment were higher among individuals who subsequently experienced recurrent parasitaemia compared to those who remained free of parasites until day 42 after initiation of treatment (p\n                      <jats:sub>day 14<\/jats:sub>\n                      \u2009=\u20090.011 and p\n                      <jats:sub>day 28<\/jats:sub>\n                      \u2009=\u20090.068). No association of ring-stage persistence with gametocyte carriage was observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The current findings of lower ring-stage persistence after ACT without an effect of gametocytocidal partner drugs affirms the use of\n                      <jats:italic>sbp1<\/jats:italic>\n                      as ring-stage marker. Lower persistence of ring-stage mRNA after ACT treatment suggests the marker may not reflect dormant parasites whilst it was predictive of re-appearance of parasitaemia.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-020-03576-z","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T13:06:50Z","timestamp":1610197610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42\u00a0days after artemisinin and non-artemisinin combination therapy in naturally infected Malians"],"prefix":"10.1186","volume":"20","author":[{"given":"Almahamoudou","family":"Mahamar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjerstin","family":"Lanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Graumans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halimatou","family":"Diawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koualy","family":"Sanogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalifa","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidi Mohamed","family":"Niambele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roly","family":"Gosling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Drakeley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alassane","family":"Dicko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-094X","authenticated-orcid":false,"given":"Teun","family":"Bousema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle E.","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"key":"3576_CR1","volume-title":"World malaria report 2019","author":"WHO","year":"2019","unstructured":"WHO. World malaria report 2019. Geneva: World Health Organization; 2019."},{"key":"3576_CR2","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"MD Conrad","year":"2019","unstructured":"Conrad MD, Rosenthal PJ. Antimalarial drug resistance in Africa: the calm before the storm? Lancet Infect Dis. 2019;19:e338\u201351.","journal-title":"Lancet Infect Dis"},{"key":"3576_CR3","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana JM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13R561H mutant parasites in Rwanda. Nat Med. 2020;26:1602\u20138.","journal-title":"Nat Med"},{"key":"3576_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ijid.2020.03.082","volume":"95","author":"A Kone","year":"2020","unstructured":"Kone A, Sissoko S, Fofana B, Sangare CO, Dembele D, Haidara AS, et al. Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy. Int J Infect Dis. 2020;95:399\u2013405.","journal-title":"Int J Infect Dis"},{"key":"3576_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/1475-2875-10-339","volume":"10","author":"JA Flegg","year":"2011","unstructured":"Flegg JA, Guerin PJ, White NJ, Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J. 2011;10:339.","journal-title":"Malar J"},{"key":"3576_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12936-020-03235-3","volume":"19","author":"R Mwaiswelo","year":"2020","unstructured":"Mwaiswelo R, Ngasala B. Evaluation of residual submicroscopicPlasmodium falciparum parasites 3 days after initiation of treatment with artemisinin-based combination therapy. Malar J. 2020;19:162.","journal-title":"Malar J"},{"key":"3576_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4269\/ajtmh.16-0893","volume":"97","author":"FG Tadesse","year":"2017","unstructured":"Tadesse FG, Lanke K, Nebie I, Schildkraut JA, Gon\u00e7alves BP, Tiono AB, et al. Molecular markers for sensitive detection of Plasmodium falciparum asexual stage parasites and their application in a malaria clinical trial. Am J Trop Med Hyg. 2017;97:188\u201398.","journal-title":"Am J Trop Med Hyg"},{"key":"3576_CR8","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/infdis\/jit431","volume":"208","author":"KB Beshir","year":"2013","unstructured":"Beshir KB, Sutherland CJ, Sawa P, Drakeley CJ, Okell L, Mweresa CK, et al. Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J Infect Dis. 2013;208:2017\u201324.","journal-title":"J Infect Dis"},{"key":"3576_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12916-016-0621-7","volume":"14","author":"WWARN Gametocyte Study Group","year":"2016","unstructured":"WWARN Gametocyte Study Group. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. BMC Med. 2016;14:79.","journal-title":"BMC Med"},{"key":"3576_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ebiom.2017.10.003","volume":"25","author":"MV Homann","year":"2017","unstructured":"Homann MV, Emami SN, Yman V, Stenstr\u00f6m C, Sond\u00e9n K, Ramstr\u00f6m H, et al. Detection of malaria parasites after treatment in travelers: a 12-months longitudinal study and statistical modelling analysis. EBioMedicine. 2017;25:66\u201372.","journal-title":"EBioMedicine"},{"key":"3576_CR11","doi-asserted-by":"publisher","first-page":"26330","DOI":"10.1038\/srep26330","volume":"6","author":"H-H Chang","year":"2016","unstructured":"Chang H-H, Meibalan E, Zelin J, Daniels R, Eziefula AC, Meyer EC, et al. Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda. Sci Rep. 2016;6:26330.","journal-title":"Sci Rep"},{"key":"3576_CR12","unstructured":"Kyle D, Webster H. Postantibiotic effect of quinine and dihydroartemisinin derivatives on Plasmodium falciparum in vitro: implications for a mechanism of recrudescence. In: XIVth international congress for tropical medicine and malaria; 1996. Abstract 022-6."},{"key":"3576_CR13","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1086\/656478","volume":"202","author":"F Nosten","year":"2010","unstructured":"Nosten F. Waking the sleeping beauty. J Infect Dis. 2010;202:1300\u20131.","journal-title":"J Infect Dis"},{"key":"3576_CR14","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1086\/656476","volume":"202","author":"F Teuscher","year":"2010","unstructured":"Teuscher F, Gatton ML, Chen N, Peters J, Kyle DE, Cheng Q. Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J Infect Dis. 2010;202:1362\u20138.","journal-title":"J Infect Dis"},{"key":"3576_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa562","author":"C Peatey","year":"2020","unstructured":"Peatey C, Chen N, Gresty K, Anderson K, Pickering P, Watts R, et al. Dormant Plasmodium falciparum parasites in human infections following artesunate therapy. J Infect Dis. 2020. https:\/\/doi.org\/10.1093\/infdis\/jiaa562.","journal-title":"J Infect Dis"},{"key":"3576_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1473-3099(18)30044-6","volume":"18","author":"A Dicko","year":"2018","unstructured":"Dicko A, Roh ME, Diawara H, Mahamar A, Soumare HM, Lanke K, et al. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial. Lancet Infect Dis. 2018;18:627\u201339.","journal-title":"Lancet Infect Dis"},{"key":"3576_CR17","volume-title":"Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations: informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization, 29\u201331 May 2007","author":"WHO","year":"2008","unstructured":"WHO. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations: informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization, 29\u201331 May 2007. Amsterdam: World Health Organization; 2008."},{"key":"3576_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"3576_CR19","doi-asserted-by":"publisher","first-page":"e26005","DOI":"10.1371\/journal.pone.0026005","volume":"6","author":"S Borrmann","year":"2011","unstructured":"Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, et al. Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. PLoS ONE. 2011;6:e26005.","journal-title":"PLoS ONE"},{"key":"3576_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/infdis\/jix622","volume":"217","author":"MM Plucinski","year":"2018","unstructured":"Plucinski MM, Dimbu PR, Fortes F, Abdulla S, Ahmed S, Gutman J, et al. Posttreatment HRP2 clearance in patients with uncomplicated Plasmodium falciparum malaria. J Infect Dis. 2018;217:685\u201392.","journal-title":"J Infect Dis"},{"key":"3576_CR21","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1172\/JCI98012","volume":"128","author":"KA Collins","year":"2018","unstructured":"Collins KA, Wang CY, Adams M, Mitchell H, Rampton M, Elliott S, et al. A controlled human malaria infection model enabling evaluation of transmission-blocking interventions. J Clin Invest. 2018;128:1551\u201362.","journal-title":"J Clin Invest"},{"key":"3576_CR22","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1038\/ncomms6606","volume":"5","author":"LC Okell","year":"2014","unstructured":"Okell LC, Cairns M, Griffin JT, Ferguson NM, Tarning J, Jagoe G, et al. Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis. Nat Commun. 2014;5:5606.","journal-title":"Nat Commun"},{"key":"3576_CR23","doi-asserted-by":"publisher","first-page":"e31549","DOI":"10.7554\/eLife.31549","volume":"7","author":"IJ Reuling","year":"2018","unstructured":"Reuling IJ, Van De Schans LA, Coffeng LE, Lanke K, Meerstein-Kessel L, Graumans W, et al. A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparumgametocytemia in the controlled human malaria infection model. Elife. 2018;7:e31549.","journal-title":"Elife"},{"key":"3576_CR24","first-page":"e1007371","volume":"14","author":"P Schneider","year":"2018","unstructured":"Schneider P, Greischar MA, Birget PL, Repton C, Mideo N, Reece SE. Adaptive plasticity in the gametocyte conversion rate of malaria parasites. PLoSPathog. 2018;14:e1007371.","journal-title":"PLoSPathog"},{"key":"3576_CR25","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1086\/587645","volume":"197","author":"KI Barnes","year":"2008","unstructured":"Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, et al. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. J Infect Dis. 2008;197:1605\u201313.","journal-title":"J Infect Dis"},{"key":"3576_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.4269\/ajtmh.2007.77.438","volume":"77","author":"F M\u00e9ndez","year":"2007","unstructured":"M\u00e9ndez F, Herrera S, Murrain B, Guti\u00e9rrez A, Moreno LA, Manzano M, et al. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes. Am J Trop Med Hyg. 2007;77:438\u201343.","journal-title":"Am J Trop Med Hyg"},{"key":"3576_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0035-9203(51)80020-8","volume":"44","author":"PG Shute","year":"1951","unstructured":"Shute PG, Maryon M. A study of gametocytes in a West African strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1951;44:421\u201338.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3576_CR28","doi-asserted-by":"publisher","first-page":"e19010","DOI":"10.1371\/journal.pone.0019010","volume":"6","author":"C Koepfli","year":"2011","unstructured":"Koepfli C, Schoepflin S, Bretscher M, Lin E, Kiniboro B, Zimmerman PA, et al. How much remains undetected? Probability of molecular detection of human Plasmodia in the field. PLoS ONE. 2011;6:e19010.","journal-title":"PLoS ONE"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03576-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-020-03576-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03576-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T13:22:39Z","timestamp":1610198559000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03576-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3576"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03576-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-77458\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,9]]},"assertion":[{"value":"13 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}